JUVÉDERM VOLLURE™ XC
JUVÉDERM VOLLURE™ XC is approved by the FDA for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds.
JUVÉDERM VOLLURE™ XC is the first and only hyaluronic acid (HA) dermal filler to last up to 18 months with optimal treatment.
JUVÉDERM VOLLURE™ XC is formulated with Allergan’s proprietary VYCROSS® technology, which blends different molecular weights of hyaluronic acid to create a tailored gel without compromising duration as assessed by in vitro studies. Allergan first debuted VYCROSS® technology in JUVÉDERM VOLUMA® XC, formulated to add volume in the cheek area, followed by JUVÉDERM VOLBELLA® XC for lip augmentation and correction of perioral rhytids (lip lines). JUVÉDERM VOLLURE XC™ has a specific balance of gel firmness and low cohesivity, yielding a versatile formulation that adds subtle volume for the correction of moderate to severe facial wrinkles and folds such as the nasolabial folds(laugh lines).
JUVÉDERM® Ultra Plus XC is a more highly cross-linked, robust gel, while JUVÉDERM VOLLURE™ XC adds subtle, softer volume, so physicians now have an additional treatment option for patients. Your doctor will decide which product is most appropriate based on your specific needs and treatment goals.
The JUVÉDERM® Collection of fillers is the number one selling collection of dermal filler products in the world.